Brett Favre endorses concussion treatment drug

Brett Favre explains the potential of the new drug Prevacus
Brett Favre explains the potential of the new drug Prevacus

HATTIESBURG, MS (WDAM) - A concussion treatment drug patented back in 2011 is pending approval by the Food and Drug Administration, and it's being endorsed by NFL great and Pine Belt native Brett Favre.

The drug is set to be in human clinical trials next year.

In November 2013, the quarterback and future NFL Hall-of-Famer told The Today Show's Matt Lauer that if he had a son, he'd be "leery about letting him play football."

On Monday, Favre took the same sentiment even further.

"It's a violent sport for two reasons," said Favre. "The pressures to, ya know, live up to what your dad had done, but most importantly the damage that is done by playing. I don't know if I would let him play."

Favre played 20 years in the NFL, the cumulative effect of his concussions is yet to be known, but according to Favre,  it's probably not great.

Favre referred to the cumulative effect of concussions, and is now endorsing Prevacus, a breakthrough nasal spray.

"After you have ea concussion, you have temporary energy crisis in the brain," said Jacob Vanlandhigham, the inventor of Prevacus. "But by using our drug as soon as possible, and for many day afterward to manage the condition, you can reduce the secondary damage that occurs after the concussion."

Vanlandingham added that it is safer to use than Tylenol. According to, it would reduce cell death, brain swelling, and inflammation.

Favre said if he got a concussion today, he'd use the spray.

"As far as stopping the advancement of a concussion, I think is unbelievable, said Favre."

Favre joined the Sports Advisory Board for Prevacus Incorporated this year, and said he is using all of his connections and his heart to try to find a cure for concussion. Favre also said he would do anything he could to help get the drug into the market.

Copyright 2014 WDAM-TV. All rights reserved.